Literature DB >> 29037046

ADMET Evaluation in Drug Discovery. 18. Reliable Prediction of Chemical-Induced Urinary Tract Toxicity by Boosting Machine Learning Approaches.

Tailong Lei1, Huiyong Sun1, Yu Kang1, Feng Zhu1, Hui Liu1, Wenfang Zhou1, Zhe Wang1, Dan Li1, Youyong Li2, Tingjun Hou1,3.   

Abstract

Xenobiotic chemicals and their metabolites are mainly excreted out of our bodies by the urinary tract through the urine. Chemical-induced urinary tract toxicity is one of the main reasons that cause failure during drug development, and it is a common adverse event for medications, natural supplements, and environmental chemicals. Despite its importance, there are only a few in silico models for assessing urinary tract toxicity for a large number of compounds with diverse chemical structures. Here, we developed a series of qualitative and quantitative structure-activity relationship (QSAR) models for predicting urinary tract toxicity. In our study, the recursive feature elimination method incorporated with random forests (RFE-RF) was used for dimension reduction, and then eight machine learning approaches were used for QSAR modeling, i.e., relevance vector machine (RVM), support vector machine (SVM), regularized random forest (RRF), C5.0 trees, eXtreme gradient boosting (XGBoost), AdaBoost.M1, SVM boosting (SVMBoost), and RVM boosting (RVMBoost). For building classification models, the synthetic minority oversampling technique was used to handle the imbalance data set problem. Among all the machine learning approaches, SVMBoost based on the RBF kernel achieves both the best quantitative (qext2 = 0.845) and qualitative predictions for the test set (MCC of 0.787, AUC of 0.893, sensitivity of 89.6%, specificity of 94.1%, and global accuracy of 90.8%). The application domains were then analyzed, and all of the tested chemicals fall within the application domain coverage. We also examined the structure features of the chemicals with large prediction errors. In brief, both the regression and classification models developed by the SVMBoost approach have reliable prediction capability for assessing chemical-induced urinary tract toxicity.

Entities:  

Keywords:  boosting; ensembles; imbalanced classification; machine learning; nephrotoxicity; quantitative structure−activity relationship; support vector machine; urinary tract toxicity

Mesh:

Year:  2017        PMID: 29037046     DOI: 10.1021/acs.molpharmaceut.7b00631

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  17 in total

1.  Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity.

Authors:  Chuipu Cai; Pengfei Guo; Yadi Zhou; Jingwei Zhou; Qi Wang; Fengxue Zhang; Jiansong Fang; Feixiong Cheng
Journal:  J Chem Inf Model       Date:  2019-02-15       Impact factor: 4.956

2.  Application of machine learning with multiparametric dual-energy computed tomography of the breast to differentiate between benign and malignant lesions.

Authors:  Xiaosong Lan; Xiaoxia Wang; Jun Qi; Huifang Chen; Xiangfei Zeng; Jinfang Shi; Daihong Liu; Hesong Shen; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Prediction and Screening Model for Products Based on Fusion Regression and XGBoost Classification.

Authors:  Jiaju Wu; Linggang Kong; Ming Yi; Qiuxian Chen; Zheng Cheng; Hongfu Zuo; Yonghui Yang
Journal:  Comput Intell Neurosci       Date:  2022-07-31

4.  In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities.

Authors:  Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Lisa Beilke; Andreas Bender; Autumn Bernal; Mark T D Cronin; Jui-Hua Hsieh; Candice Johnson; Raymond Kemper; Moiz Mumtaz; Louise Neilson; Manuela Pavan; Amy Pointon; Julia Pletz; Patricia Ruiz; Daniel P Russo; Yogesh Sabnis; Reena Sandhu; Markus Schaefer; Lidiya Stavitskaya; David T Szabo; Jean-Pierre Valentin; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-13

Review 5.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

6.  ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.

Authors:  Dejun Jiang; Tailong Lei; Zhe Wang; Chao Shen; Dongsheng Cao; Tingjun Hou
Journal:  J Cheminform       Date:  2020-03-05       Impact factor: 5.514

7.  Structure-activity relationship-based chemical classification of highly imbalanced Tox21 datasets.

Authors:  Gabriel Idakwo; Sundar Thangapandian; Joseph Luttrell; Yan Li; Nan Wang; Zhaoxian Zhou; Huixiao Hong; Bei Yang; Chaoyang Zhang; Ping Gong
Journal:  J Cheminform       Date:  2020-10-27       Impact factor: 5.514

8.  Improvement of Prediction Performance With Conjoint Molecular Fingerprint in Deep Learning.

Authors:  Liangxu Xie; Lei Xu; Ren Kong; Shan Chang; Xiaojun Xu
Journal:  Front Pharmacol       Date:  2020-12-18       Impact factor: 5.810

9.  Derivation and Validation of Machine Learning Approaches to Predict Acute Kidney Injury after Cardiac Surgery.

Authors:  Hyung-Chul Lee; Hyun-Kyu Yoon; Karam Nam; Youn Joung Cho; Tae Kyong Kim; Won Ho Kim; Jae-Hyon Bahk
Journal:  J Clin Med       Date:  2018-10-03       Impact factor: 4.241

10.  Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase.

Authors:  Robert Ancuceanu; Bogdan Tamba; Cristina Silvia Stoicescu; Mihaela Dinu
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.